{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:21:22Z","timestamp":1792552882444,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.apjo.2026.100328","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:30:12Z","timestamp":1778578212000},"page":"100328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global approval and certification of ophthalmic AI devices: A comparative regulatory perspective"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-2391","authenticated-orcid":false,"given":"Andrzej","family":"Grzybowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Y. Alvin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6586-4096","authenticated-orcid":false,"given":"Ally","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-3764","authenticated-orcid":false,"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5331-4730","authenticated-orcid":false,"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-6890","authenticated-orcid":false,"given":"Polat","family":"Goktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4369-2417","authenticated-orcid":false,"given":"Kai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjo.2026.100328_bib1","article-title":"Exploring large language model for next generation of artificial intelligence in ophthalmology","volume":"10","author":"Jin","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40123-023-00691-3","article-title":"Artificial intelligence for diabetic retinopathy screening using color retinal photographs: from development to deployment","volume":"12","author":"Grzybowski","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"10.1016\/j.apjo.2026.100328_bib3","first-page":"1893","article-title":"Balancing the promises and challenges of artificial intelligence in ophthalmology","volume":"13","author":"Goktas","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib4","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S2214-109X(23)00037-2","article-title":"AI telemedicine screening in ophthalmology: health economic considerations","volume":"11","author":"Santarsiero","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.apjo.2026.100328_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100900","article-title":"Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective","volume":"82","author":"Li","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.apjo.2026.100328_bib6","first-page":"1739","article-title":"Diagnosing systemic disorders with AI algorithms based on ocular images","volume":"11","author":"Li","year":"2023","journal-title":"Healthc (Basel)"},{"key":"10.1016\/j.apjo.2026.100328_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101034","article-title":"Trustworthy AI: closing the gap between development and integration of AI systems in ophthalmic practice","volume":"90","author":"Gonz\u00e1lez-Gonzalo","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.apjo.2026.100328_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.241873","article-title":"Ethical and legal considerations in healthcare AI: innovation and policy for safe and fair use","volume":"12","author":"Pham","year":"2025","journal-title":"R Soc Open Sci"},{"issue":"8","key":"10.1016\/j.apjo.2026.100328_bib9","first-page":"13","article-title":"The \"black box\"of artificial intelligence in ophthalmology","volume":"20","author":"Blanckaert","year":"2024","journal-title":"Ophthalmol Eur"},{"key":"10.1016\/j.apjo.2026.100328_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/12460125.2024.2410042","article-title":"Ethics, transparency, and explainability in generative AI decision-making systems: a comprehensive bibliometric study","volume":"33","author":"Goktas","year":"2024","journal-title":"J Decis Syst"},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib11","article-title":"How AI challenges the medical device regulation: patient safety, benefits, and intended uses","volume":"11","author":"Onitiu","year":"2024","journal-title":"J Law Biosci"},{"issue":"4","key":"10.1016\/j.apjo.2026.100328_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26297","article-title":"Ethical and regulatory challenges of AI technologies in healthcare: a narrative review","volume":"10","author":"Mennella","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.apjo.2026.100328_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/jcm14051605","article-title":"Shaping the future of healthcare: ethical clinical challenges and pathways to trustworthy AI","volume":"14","author":"Goktas","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.apjo.2026.100328_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","article-title":"The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database","volume":"3","author":"Benjamens","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apjo.2026.100328_bib15","article-title":"The global regulatory landscape for AI\/ML-enabled medical devices","author":"Kulshreshtha","year":"2025","journal-title":"Regul Focus"},{"key":"10.1016\/j.apjo.2026.100328_bib16","unstructured":"UK Medicines & Healthcare Products Regulatory Agency. Software and AI as a Medical Device Change Programme Roadmap. 2023."},{"key":"10.1016\/j.apjo.2026.100328_bib17","unstructured":"International Medical Device Regulators Forum. Good Machine Learning Practice for Medical Device Development: Guiding Principles. Final document. 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib18","unstructured":"U.S. Food and Drug Administration, Good Machine Learning Practice for Medical Device Development: Guiding Principles. Published October 27, 2021. Accessed April 21, 2026."},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/electronics13030498","article-title":"FDA-approved artificial intelligence and machine learning-enabled medical devices: an updated landscape","volume":"13","author":"Joshi","year":"2024","journal-title":"Electronics"},{"key":"10.1016\/j.apjo.2026.100328_bib20","unstructured":"Rajesh A., Lee A. AI for diabetic retinopathy screening: where are we in 2025? Retina Specialist. Published 2025. Accessed August 15, 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib21","unstructured":"Digital Diagnostics. LumineticsCore: a letter from the CEO. Published 2023. Accessed August 15, 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib22","series-title":"Ikerian receives EU MDR certificate for ophthalmology data platform and AI models","author":"Ikerian","year":"2025"},{"key":"10.1016\/j.apjo.2026.100328_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","article-title":"Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care","volume":"1","author":"Abr\u00e0moff","year":"2018","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apjo.2026.100328_bib24","unstructured":"Eyenuk Inc. Eyenuk secures EU MDR certification for autonomous AI detection of diabetic retinopathy, age-related macular degeneration, and glaucoma. Published 2023. Accessed August 15, 2025."},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jamia\/ocad199","article-title":"Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI","volume":"31","author":"Lee","year":"2024","journal-title":"J Am Med Inf Assoc"},{"key":"10.1016\/j.apjo.2026.100328_bib26","unstructured":"Mediwhale Dr. Noon C.V.D. Regulatory information page. Accessed April 21, 2026."},{"key":"10.1016\/j.apjo.2026.100328_bib27","unstructured":"Toku. Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye. Published February 5, 2024. Accessed April 21, 2026."},{"key":"10.1016\/j.apjo.2026.100328_bib28","unstructured":"Toku. FDA grants Breakthrough Device status to Toku's patented cardiovascular risk AI (CLAiR) platform. Published November 2, 2023. Accessed April 21, 2026."},{"key":"10.1016\/j.apjo.2026.100328_bib29","unstructured":"Therapeutic Goods Administration. TeleMedC Pty Ltd-Automated Retinopathy Analysis System: annual charge exemption (2023-24). 2023."},{"key":"10.1016\/j.apjo.2026.100328_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40123-023-00652-w","article-title":"Approval and certification of ophthalmic AI devices in the European Union","volume":"12","author":"Grzybowski","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.apjo.2026.100328_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1167\/tvst.9.2.45","article-title":"Current challenges and barriers to real-world artificial intelligence adoption","volume":"9","author":"Singh","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.apjo.2026.100328_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41746-024-01254-x","article-title":"Regulatory responses and approval status of artificial intelligence medical devices in China","volume":"7","author":"Liu","year":"2024","journal-title":"NPJ Digit Med"},{"issue":"4","key":"10.1016\/j.apjo.2026.100328_bib33","first-page":"209","article-title":"Improving public services using artificial intelligence","volume":"42","author":"Henman","year":"2020","journal-title":"Asia Pac J Public Adm"},{"key":"10.1016\/j.apjo.2026.100328_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2024.1267290","article-title":"A trustworthy AI reality-check: lack of transparency of artificial intelligence products in healthcare","volume":"6","author":"Fehr","year":"2024","journal-title":"Front Digit Health"},{"key":"10.1016\/j.apjo.2026.100328_bib35","unstructured":"U.S. Food and Drug Administration. Artificial Intelligence\/Machine Learning (AI\/ML)-Based Software as a Medical Device Action Plan. 2021."},{"key":"10.1016\/j.apjo.2026.100328_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s44174-023-00113-9","article-title":"A review of biomedical devices: classification, regulatory guidelines, software as a medical device, and cybersecurity","volume":"2","author":"Tettey","year":"2024","journal-title":"Biomed Mater Devices"},{"key":"10.1016\/j.apjo.2026.100328_bib37","unstructured":"US Food and Drug Administration. Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Draft Guidance. 2023."},{"key":"10.1016\/j.apjo.2026.100328_bib38","unstructured":"Ropes & Gray. Getting smarter: FDA draft guidance on predetermined change control plans for AI\/ML devices. Published 2023. Accessed August 15, 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib39","article-title":"Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions","author":"Food","year":"2024","journal-title":"Draft Guid"},{"key":"10.1016\/j.apjo.2026.100328_bib40","first-page":"1","article-title":"Council of the European Union. Regulation (EU) 2017\/745 on medical devices","author":"European Parliament","year":"2017","journal-title":"J Eur Union"},{"key":"10.1016\/j.apjo.2026.100328_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmp.2021.02.011","article-title":"The EU medical device regulation: implications for artificial intelligence-based medical device software","volume":"83","author":"Beckers","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.apjo.2026.100328_bib42","unstructured":"European Commission. AI Act enters into force. Published August 1, 2024. Accessed April 21, 2026."},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14763\/2024.3.1784","article-title":"The European approach to regulating artificial intelligence through technical standards","volume":"13","author":"Gornet","year":"2024","journal-title":"Internet Policy Rev"},{"issue":"6","key":"10.1016\/j.apjo.2026.100328_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17434440.2023.2184685","article-title":"Artificial intelligence in medical device software and high-risk medical devices","volume":"20","author":"Fraser","year":"2023","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.apjo.2026.100328_bib45","unstructured":"Qualtech. Australia: TGA updates guidance for software-based medical devices. Published 2024. Accessed August 15, 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib46","unstructured":"Therapeutic Goods Administration. Australian Register of Therapeutic Goods entry 374576: TeleMedC Pty Ltd-Automated Retinopathy Analysis System. 2021."},{"key":"10.1016\/j.apjo.2026.100328_bib47","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-020-01685-x","article-title":"Evaluation of an AI-based screening system for diabetic retinopathy in China: a real-world study","volume":"41","author":"Ming","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12913-022-07655-6","article-title":"Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.apjo.2026.100328_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/AIp2401234","article-title":"The landscape of medical artificial intelligence in China","volume":"2","author":"Qiu","year":"2025","journal-title":"NEJM AI"},{"key":"10.1016\/j.apjo.2026.100328_bib50","unstructured":"China National Medical Products Administration. Clinical Evaluation Guideline on Artificial Intelligence-Assisted Detection Software. 2023."},{"key":"10.1016\/j.apjo.2026.100328_bib51","article-title":"China's NMPA: the evolution of medical device regulation","author":"Palma","year":"2022","journal-title":"Regul Aff Prof Soc"},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjo.2024.08.013","article-title":"Integrating AI with tele-ophthalmology in Canada: a review","volume":"60","author":"Balas","year":"2025","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100328_bib53","unstructured":"Remidio. Remidio receives CDSCO approval for AI tools to detect glaucoma and age-related macular degeneration. Published 2025. Accessed August 15, 2025."},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib54","first-page":"329","article-title":"AI in Indian healthcare: from roadmap to reality","volume":"2","author":"Das","year":"2024","journal-title":"Intell Pharm"},{"issue":"2","key":"10.1016\/j.apjo.2026.100328_bib55","article-title":"AI horizons in Indian healthcare","volume":"49","author":"Kapoor","year":"2024","journal-title":"Indian J Community Med"},{"key":"10.1016\/j.apjo.2026.100328_bib56","doi-asserted-by":"crossref","DOI":"10.20529\/IJME.2025.037","article-title":"A framework for governance of artificial intelligence in healthcare in India","author":"Naik","year":"2025","journal-title":"Indian J Med Ethics"},{"key":"10.1016\/j.apjo.2026.100328_bib57","unstructured":"VUNO. VUNO Med-Fundus AI. Product page. Accessed April 21, 2026."},{"key":"10.1016\/j.apjo.2026.100328_bib58","unstructured":"Agencia Nacional de Vigilancia Sanitaria (ANVISA). Medical devices and Software as Medical Device regulation in Brazil. Updated March 21, 2026. Accessed April 21, 2026."},{"issue":"2","key":"10.1016\/j.apjo.2026.100328_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100141","article-title":"Emerging ethical considerations for artificial intelligence in ophthalmology","volume":"2","author":"Evans","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.apjo.2026.100328_bib60","unstructured":"International Medical Device Regulators Forum. Machine Learning-Enabled Medical Devices: Key Terms and Definitions. 2022."},{"key":"10.1016\/j.apjo.2026.100328_bib61","unstructured":"European Commission. Proposal for a regulation laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). COM\/2021\/206 final. 2021."},{"issue":"4","key":"10.1016\/j.apjo.2026.100328_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3419764","article-title":"Bridging the gap between ethics and practice: guidelines for trustworthy human-centered AI","volume":"10","author":"Shneiderman","year":"2020","journal-title":"ACM Trans Inter Intell Syst"},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41746-025-01726-8","article-title":"A scoping review of artificial intelligence as a medical device for ophthalmic image analysis","volume":"8","author":"Ong","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apjo.2026.100328_bib64","article-title":"Remidio receives CDSCO approval in India for Medios DR AI","author":"Crago","year":"2025","journal-title":"Mod Retin"},{"issue":"2","key":"10.1016\/j.apjo.2026.100328_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bjophthalmol-2018-313173","article-title":"Artificial intelligence and deep learning in ophthalmology","volume":"104","author":"Ting","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100328_bib66","series-title":"Artificial Intelligence for a Better Future","author":"Stahl","year":"2021"},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17579961.2021.1898300","article-title":"From a race to AI to a race to AI regulation","volume":"13","author":"Smuha","year":"2021","journal-title":"Law Innov Technol"},{"key":"10.1016\/j.apjo.2026.100328_bib68","series-title":"Ethics and Governance of Artificial Intelligence for Health","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.apjo.2026.100328_bib69","unstructured":"Regulatory Affairs Professionals Society. Global regulatory landscape for AI\/ML-enabled medical devices. 2022. Accessed August 15, 2025."},{"issue":"10","key":"10.1016\/j.apjo.2026.100328_bib70","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2589-7500(20)30218-1","article-title":"Reporting guidelines for clinical trials evaluating artificial intelligence interventions: CONSORT-AI extension","volume":"2","author":"Liu","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"10","key":"10.1016\/j.apjo.2026.100328_bib71","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/S2589-7500(20)30219-3","article-title":"SPIRIT-AI extension: guidelines for clinical trial protocols involving artificial intelligence","volume":"2","author":"Rivera","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"1","key":"10.1016\/j.apjo.2026.100328_bib72","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41467-024-45355-3","article-title":"Concordance of randomized controlled trials with CONSORT-AI reporting guidelines","volume":"15","author":"Martindale","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apjo.2026.100328_bib73","unstructured":"ISO\/IEC. ISO\/IEC 23894:2023-Information technology-Artificial intelligence-Guidance on risk management. 2023."},{"key":"10.1016\/j.apjo.2026.100328_bib74","unstructured":"World Health Organization. Ethics and Governance of Artificial Intelligence for Health: Guidance on Large Multimodal Models. 2025."},{"key":"10.1016\/j.apjo.2026.100328_bib75","unstructured":"Lekadir K., Osuala R., Gallin C., et al. FUTURE-AI: guiding principles for trustworthy AI in medical imaging. arXiv. 2021;arXiv:2109.09658."},{"issue":"3","key":"10.1016\/j.apjo.2026.100328_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/APO.0000000000000525","article-title":"Patients' perceptions of artificial intelligence in diabetic eye screening","volume":"11","author":"Yap","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216209892600054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216209892600054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T08:00:56Z","timestamp":1780214456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216209892600054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S216209892600054X"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2026.100328","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global approval and certification of ophthalmic AI devices: A comparative regulatory perspective","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2026.100328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100328"}}